Rome, Italy

Claudio Milanese

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Claudio Milanese: Innovator in Pharmaceutical Advances**

Introduction

Claudio Milanese, an accomplished inventor based in Rome, Italy, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, his work primarily focuses on innovative compositions that advance the treatment of various medical conditions.

Latest Patents

Among Milanese's notable patents is a pharmaceutical composition designed for the treatment of mycosis. This invention centers on a unique combination of benzydamine and an antimycotic active ingredient, which exhibits a synergistic effect in combating mycosis. Another important patent addresses the reduction of MCP-1 protein production, utilizing a specific compound and its salts, which aids in developing therapeutic strategies for disorders associated with increased MCP-1 levels.

Career Highlights

Milanese has had a fruitful career, having worked with prominent companies such as Aziende Chimiche Riunite Angelini, A.C.R.A.F. S.p.A., and Angelini Ricerche S.p.A. Società Consortile. His experiences in these organizations have undoubtedly influenced his innovative approach to pharmaceutical research and development.

Collaborations

Throughout his career, Milanese has collaborated with esteemed colleagues, including Mario Pinza and Mario Brufani. Their combined expertise in the pharmaceutical industry has complemented Milanese's innovative ideas, promoting progress in the sector.

Conclusion

Claudio Milanese stands out as a key figure in the pharmaceuticals landscape, leveraging his inventive spirit to develop compositions that tackle challenging medical conditions. As he continues his journey, his contributions promise to have lasting impacts on healthcare and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…